GIMSILUMAB
UNII 8961SFA7R3

Substance Identification & Data

This profile provides standardized clinical and technical data for Gimsilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8961SFA7R3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1648796-29-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8961SFA7R3
CAS Registry Number
1648796-29-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GIMSILUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C172615
National Cancer Institute reference terminology for clinical and research data.
INN ID
10534
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
CD-160
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gimsilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GIMSILUMAB

Common Names & Synonyms

GIMSILUMAB [INN]
GIMSILUMAB [USAN]
GIMSILUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN MONOCLONAL MORAB-022 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MORAB-022 .KAPPA.-CHAIN, DIMER

Technical Codes

MORAB022
MORAB-022

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus